Merck Animal Health Expands Vaccine Portfolio and Manufacturing Capabilities with Acquisition of Prondil S.A.
(WorldNews Netherlands)

6 December 2017 MADISON, N.J., December 6- Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced it has acquired Prondil S.A., a privately-held company specializing in development and manufacturing of animal health vaccines for livestock. Specific terms of the agreement were not disclosed. Prondil, located in Montevideo, Uruguay, is an internationally-recognized supplier of quality antigens and vaccines for veterinary use. The company`s wide range of products are sold in over 20 countries. `At Merck Animal Health we continue to execute upon our strategy to expand our vaccine leadership and add more breadth to our portfolio,` said Rick DeLuca,...